Xstelos Holdings, Inc. (XTLS) Return on Investment ROI from the third quarter of 2013 to third quarter of 2012 and for the year 2013, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Xstelos Holdings, Inc.  (XTLS)


Xstelos Holdings,'s ROI from its third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Xstelos Holdings,'s ROI in the third quarter of 2013?
Xstelos Holdings, Inc. achieved a return on average invested assets (ROI) of 14.33 % in its third quarter of 2013, which is below Xstelos Holdings,'s average return on investment, which stands at 21.81%.

ROI decreased relative to the period ending Jun 30 2013, due to the decline in net income.

Within the Healthcare sector 38 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2013 from 0 to 352.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Investment Change TTM 34.33 % 123.31 % 359.88 % - -
Y / Y Net Income Change TTM -37.83 % -24.17 % 1541.82 % - -
Investment (TTM) in Millions 97 98 100 101 111
Return On Investment (TTM) 14.33 % 15.39 % 33.39 % 36.59 % 30.97 %
XTLS's Overall Ranking # 352 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -3.39 % 0.73 % 2.83 % 34.24 % 60.6 %
Seq. Net Income Change TTM -10.01 % -53.58 % -6.16 % 58.59 % 9.76 %
Net Income (TTM) in Millions 14 16 34 36 23

XTLS Company Profile >> Back to XTLS Roi Comparisons >> See Annual XTLS Return On Investment



Return On Investment XTLS's Ranking
Within: No.
Industry # 9
Sector # 39
Overall # 352

Return On Investment Statistics
High Average Low
36.59 %
21.81 %
9.35 %
(Dec 31 2012)   (Mar 31 2012)







Financial Statements
Xstelos Holdings,'s III. Quarter Investments $ 97 Millions XTLS's Balance sheet
Xstelos Holdings,'s III. Quarter Income $ 0 Millions Quarterly XTLS's Income Statement
XTLS's Income by Division See XTLS's Income by Division


XTLS Annual Return On Investment (Dec 31 2012)
2012



Total Investments in Millions 101 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 36 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 35.87 % - - - -


Annual Roi Comment
In the fiscal year 2012 ROI improved to 35.87 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XTLS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XTLS's Competitors
Subscribers only: Roi for Xstelos Holdings,'s Suppliers
Subscribers only: Return On Investment for XTLS's Customers

Other Ratios
XTLS's Roa XTLS's Inventory Turnover Ratio XTLS's Growth Rates XTLS's Dividend Statistics
XTLS's Profitability Ratios XTLS's Asset Turnover Ratio XTLS's Dividend Growth
XTLS's Roe XTLS's Valuation Ratios XTLS's Financial Strength Ratios XTLS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2013, within Healthcare Sector ROI
Camp4 Therapeutics Corporation  39.20 %
Regeneron Pharmaceuticals Inc   38.47 %
Fonar Corporation  33.07 %
Cellular Biomedicine Group Inc   30.28 %
Acorda Therapeutics Inc   29.96 %
Idexx Laboratories Inc  28.81 %
China Biologic Products Holdings Inc   28.55 %
Sunlink Health Systems Inc   26.80 %
Psychemedics Corporation  25.90 %
Meridian Bioscience Inc   25.53 %
Myriad Genetics Inc   25.37 %
Elite Pharmaceuticals Inc   24.60 %
Biospecifics Technologies Corp  24.17 %
Abbvie Inc   22.87 %
Varian Medical Systems Inc   22.29 %
Repligen Corp  22.15 %
Nutrastar International Inc.  21.17 %
Nrc Health  20.81 %
United Therapeutics Corporation  20.64 %
Mettler toledo International Inc   20.59 %
Edwards Lifesciences Corporation  20.12 %
Biogen Inc   20.08 %
Lifevantage Corp  19.80 %
Addus Homecare Corp  19.52 %
Encompass Health Corporation  19.49 %
Jazz Pharmaceuticals Plc  19.34 %
Healthcare Services Group Inc   19.00 %
Intuitive Surgical Inc   18.55 %
Eli Lilly And Company  18.23 %
Cambrex Corp  17.81 %

Date modified: 2026-09-18T13:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.